Carvolix SA (EPA:CVX)
France
· Delayed Price · Currency is EUR 3.330
-0.020 (-0.60%)
At close: Mar 6, 2026
Carvolix Market Cap
Carvolix has a market cap or net worth of €197.28 million as of March 6, 2026. Its market cap has increased by 258.13% in one year.
Market Cap
197.28M
Enterprise Value
215.35M
Revenue
5.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.33
Market Cap Chart
Since June 14, 2021, Carvolix's market cap has increased from 145.31M to 197.28M, an increase of 35.77%. That is a compound annual growth rate of 6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 197.28M | 189.81% |
| Dec 31, 2025 | 68.07M | 28.15% |
| Dec 31, 2024 | 53.12M | -6.82% |
| Dec 29, 2023 | 57.01M | 86.82% |
| Dec 30, 2022 | 30.52M | -70.47% |
| Dec 31, 2021 | 103.35M | -28.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Median Technologies | 189.76M |
| Eurobio Scientific Société anonyme | 235.09M |
| Guerbet | 154.49M |
| Diagnostic Medical Systems | 32.63M |
| Implanet | 27.63M |
| Novacyt | 27.11M |
| Theraclion | 26.78M |
| Ikonisys | 24.40M |